This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 10-16 March 2024 and includes updates on SARS-CoV-2 variant classification, avian influenza, measles, cholera, and overview of respiratory virus epidemiology in the EU/EE.
This protocol describes the common methodology to be applied to established health data registries across seven participating EU/EEA Member States to estimate vaccine effectiveness for Coronavirus disease 2019 (COVID-19) in children and adolescents aged 5-17 years old.
Reporting protocol for submitting data on antimicrobial consumption to ECDC, through the European Antimicrobial Consumption Surveillance Network (ESAC-Net).
ECDC regularly assesses new evidence on variants detected through epidemic intelligence, rules-based genomic variant screening or other scientific sources.
On 15 March 2024, Dr Andrea Ammon visited the Norwegian Institute of Public Health (Folkhelseinstituttet/NIPH) and the Ministry of Health and Care Services, in Oslo.
In 2020, 11 124 (12.7%) of patients staying in an intensive care unit (ICU) for more than two days presented with at least one ICU-acquired healthcare-associated infection (HAI) under surveillance (pneumonia, bloodstream infection, or urinary tract infection).
This report summarizes the conclusions of an interview study with public health authorities in Europe and Central Asia, exploring the barriers and drivers to advancing the use of behavioural and cultural insights (BCI) for health.
Skills, resources and systems are the key challenges that need to be addressed to advance the use of behavioural and cultural insights (BCI) in countries, according to a study conducted by WHO/Europe jointly with ECDC.